PharmiWeb.com - Global Pharma News & Resources
04-Mar-2019

Next Generation Sequencing Industry Size and Forecast 2017-26: Market expected to grow at a CAGR of 18.7% during the forecast period

According to Orian Research, the Global Next Generation Sequencing market is expected to grow at a CAGR of 18.7% during the forecast period. Factors such as growing adoption of sequencing technologies in clinical applications and low-cost DNA sequencing are likely to drive the market growth. On the other side, accuracy and standardization issues and lack of skilled labor are inhibiting the market growth. However, the rise in personalized medicine and cloud computing are likely to create more opportunities for this market during the forecast period.

Next Generation Sequencing Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization. This will help to new player and existing players to survive in the global market.

Some of the key players in Next Generation Sequencing market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Illumina, Inc., Beijing Genomics Institute, Qiagen N.V., Pacific Biosciences of California, Inc., Perkinelmer, Inc., Agilent Technologies, Inc., Gatc Biotech AG, Oxford Nanopore Technologies, Ltd., Macrogen, Inc., Eurofins Scientific, Myriad Genetics, Bio-Rad Laboratories, Inc., Pieriandx, Roche Holding Ag, Genomatix Gmbh, DNASTAR Inc., Macrogen Inc. and Helicos BioSciences.

Get Sample Copy of this Report –  https://www.orianresearch.com/request-sample/611640

Depending upon the End Users, the Genetic Screening is a method used to provide important information on gene function as well as the molecular events that underlie a biological process or pathway or identify and select for individuals who possess a phenotype of interest in a mutagenized population. It totally depends on the accuracy of the test, the reliability of the interpretation of the results and the ability to treat the condition based on the quality. Apart from these, it can lessen the anxiety of not knowing the possibility of developing a disease and give a tremendous sense of relief.

By geography, North America is expected to surpass the other regions throughout the forecast period due to the support from various government bodies, like NHGRI (National Human Genome Research Institute, US) and fund research on the genome's structure, function, and role in health and disease.

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Type of Sequencing covered:

  • Whole Genome Sequencing
  • Targeted Resequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • CHIP Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • Pre-sequencing

Products Covered:

  • Instruments
  • Reagents & Consumables
  • Services
  • Platforms

About Us:

Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President – Global Sales & Partner Relations

Orian Research Consultants

US:  +1 (832) 380-8827 | UK: +44 0161-818-8027